These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33194192)

  • 1. Retrospective analysis of the effect of current clinical medications and clinicopathological factors on viral shedding in COVID-19 patients.
    Pan Y; Li Q; Yu X; Luo Q; Qin T; Xin N; Zhang Q; Li X; Du X; Zhao Q; Sun L
    Biomed Rep; 2020 Dec; 13(6):68. PubMed ID: 33194192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
    Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
    Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
    J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
    Choi MJ; Kang M; Shin SY; Noh JY; Cheong HJ; Kim WJ; Jung J; Song JY
    Int J Infect Dis; 2021 Jan; 102():275-281. PubMed ID: 33127507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19.
    Chen X; Zhu B; Hong W; Zeng J; He X; Chen J; Zheng H; Qiu S; Deng Y; Chan JCN; Wang J; Zhang Y
    Int J Infect Dis; 2020 Sep; 98():252-260. PubMed ID: 32619760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus-2 infection.
    Zhang S; Zhu H; Ye H; Hu Y; Zheng N; Huang Z; Xiong Z; Fu L; Cai T
    J Clin Lab Anal; 2021 Sep; 35(9):e23923. PubMed ID: 34390043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
    Li TZ; Cao ZH; Chen Y; Cai MT; Zhang LY; Xu H; Zhang JY; Ma CH; Liu Y; Gao LJ; Duan ZH; Mou DL; Liang LC
    J Med Virol; 2021 Jan; 93(1):506-512. PubMed ID: 32644223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
    Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
    Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
    He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
    Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
    Gao C; Zhu L; Jin CC; Tong YX; Xiao AT; Zhang S
    Clin Immunol; 2020 Dec; 221():108611. PubMed ID: 33068796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early combination therapy of COVID-19 in high-risk patients.
    Orth HM; Flasshove C; Berger M; Hattenhauer T; Biederbick KD; Mispelbaum R; Klein U; Stemler J; Fisahn M; Doleschall AD; Baermann BN; Koenigshausen E; Tselikmann O; Killer A; de Angelis C; Gliga S; Stegbauer J; Spuck N; Silling G; Rockstroh JK; Strassburg CP; Brossart P; Panse JP; Jensen BO; Luedde T; Boesecke C; Heine A; Cornely OA; Monin MB
    Infection; 2024 Jun; 52(3):877-889. PubMed ID: 38017344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan.
    Lu Y; Li Y; Deng W; Liu M; He Y; Huang L; Lv M; Li J; Du H
    Pediatr Infect Dis J; 2020 Jul; 39(7):e95-e99. PubMed ID: 32379191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study.
    Qi L; Yang Y; Jiang D; Tu C; Wan L; Chen X; Li Z
    Int J Infect Dis; 2020 Jul; 96():531-537. PubMed ID: 32425636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
    Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH
    J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period.
    Arfijanto MV; Asmarawati TP; Bramantono B; Rusli M; Rachman BE; Mahdi BA; Nasronudin N; Hadi U
    Pathophysiology; 2023 May; 30(2):186-198. PubMed ID: 37218914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study.
    Feng Z; Li J; Yao S; Yu Q; Zhou W; Mao X; Li H; Kang W; Ouyang X; Mei J; Zeng Q; Liu J; Ma X; Rong P; Wang W
    Aging Dis; 2020 Oct; 11(5):1069-1081. PubMed ID: 33014523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
    Hu F; Yin G; Chen Y; Song J; Ye M; Liu J; Chen C; Song Y; Tang X; Zhang Y
    Clin Respir J; 2020 Nov; 14(11):1067-1075. PubMed ID: 32750201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.